Rezolute to Participate in the BTIG Virtual Biotechnology Conference
July 31, 2024 08:00 ET
|
Rezolute, Inc.
REDWOOD CITY, Calif., July 31, 2024 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage biopharmaceutical company committed to developing novel,...
electroCore to Announce Second Quarter June 30, 2024 Financial Results on Wednesday, August 7, 2024
July 31, 2024 08:00 ET
|
electroCore, Inc.
ROCKAWAY, N.J., July 31, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that it will report financial...
Bionano to Report Second Quarter 2024 Financial Results and Host a Conference Call and Webcast on August 7, 2024
July 31, 2024 08:00 ET
|
Bionano Genomics
SAN DIEGO, July 31, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Wednesday, August 7, 2024, at 4:30 p.m....
Liquidia Corporation to Report Second Quarter 2024 Financial Results on August 7, 2024
July 31, 2024 08:00 ET
|
Liquidia Corporation
Liquidia Corporation to report second quarter 2024 financial results on
August 7, 2024.
Twin Disc Announces Details of Fiscal 2024 Fourth Quarter Earnings Release, Webcast, and Conference Call
July 31, 2024 08:00 ET
|
Twin Disc, Incorporated
MILWAUKEE, July 31, 2024 (GLOBE NEWSWIRE) -- Twin Disc, Inc. (NASDAQ: TWIN), today announced that it will release its fiscal 2024 fourth-quarter results at approximately 8:00 am Eastern on August...
American Oncology Network Announces Second Quarter 2024 Earnings Release Date and Conference Call
July 31, 2024 08:00 ET
|
American Oncology Network
FORT MYERS, Fla., July 31, 2024 (GLOBE NEWSWIRE) -- American Oncology Network (“AON” or the “Company”) (OTCQX: AONC), one of the fastest growing community-based oncology practices, announced today...
Fate Therapeutics Appoints Neely Mozaffarian, MD, PhD, FACR, to its Board of Directors
July 31, 2024 08:00 ET
|
Fate Therapeutics, Inc.
SAN DIEGO, July 31, 2024 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent...
Graphjet Technology Regains Compliance with Nasdaq
July 31, 2024 08:00 ET
|
Graphjet Technology Sdn Bhd
KUALA LUMPUR, Malaysia, July 31, 2024 (GLOBE NEWSWIRE) -- Graphjet Technology (“Graphjet” or “the Company”) (Nasdaq:GTI), a leading developer of patented technologies to produce graphite and...
Milestone® Pharmaceuticals to Present at the Upcoming BTIG Virtual Biotechnology Conference
July 31, 2024 08:00 ET
|
Milestone Pharmaceuticals Inc.
MONTREAL and CHARLOTTE, N.C., July 31, 2024 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nasdaq: MIST) today announced that President and CEO, Joe Oliveto, will participate in the BTIG...
ZimVie Announces the Release of RealGUIDE® 5.4 Software Update
July 31, 2024 08:00 ET
|
ZimVie Inc.
PALM BEACH GARDENS, Fla., July 31, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, today announced the release of its RealGUIDE® 5.4...